1:18supplementary video · The Bone Museum on YouTube ↗
money & economicsWellcome Collection1961–1970s · United Kingdom
Thalidomide families fought a decades-long battle that won compensation only after a press and parliamentary campaign
Thalidomide, sold in Britain by Distillers as Distaval, caused severe birth defects in babies whose mothers took it in pregnancy, and was withdrawn in Britain in 1961. Yet for years little was done to help the affected children. From 1962, parents formed groups and began a decades-long fight in the courts, the press and Parliament. The company was reluctant to admit responsibility and the government slow to offer support, so families had to take on the pharmaceutical industry themselves. Pressure, including a Sunday Times campaign in the 1970s, eventually forced a larger compensation settlement and a trust fund for survivors.
The thalidomide disaster led to modern drug-safety laws, including tougher testing and regulation of new medicines. The families' fight is an early example of patients organising to hold powerful companies to account.
Drug disasters have repeatedly produced new safety law: the 1937 Elixir Sulfanilamide deaths led to the US Food, Drug and Cosmetic Act of 1938, and thalidomide led to the 1962 Kefauver-Harris amendments.
Thalidomide is still used today under strict controls, for conditions including leprosy complications and multiple myeloma.
background
Thalidomide, sold under the brand names Contergan, Distaval and Thalomid among others, is an oral administered medication used to treat a number of cancers (e.g., multiple myeloma), graft-versus-host disease, and skin disorders (e.g., complications of leprosy such as skin lesions). Thalidomide has been used to treat conditions associated with HIV: aphthous ulcers, HIV-associated wasting syndrome, diarrhea, and Kaposi's sarcoma, but increases in HIV viral load have been reported.
Common side effects include sleepiness, rash, and dizziness. Severe side effects include tumor lysis syndrome, blood clots, and peripheral neuropathy. Thalidomide is a human teratogen and carries a high risk of severe, life-threatening birth defects if administered or taken during pregnancy. It causes skeletal deformities such as amelia (absence of legs and/or arms), absence of bones, and phocomelia (malformation of the limbs). A single dose of thalidomide, regardless of dosage, is enough to cause teratogenic effects.
From Wikipedia: Thalidomide (CC BY-SA 4.0) ↗ · text CC BY-SA 4.0Wellcome Collection · CC BY 4.0
